• Abstracts must describe new and unpublished research. Previously published work or abstracts presented at prior national or international meetings are discouraged unless substantial new data are included.
• Abstracts must be submitted in English.
• The maximum length is 2,500 characters, including spaces. Title, authors, affiliations, and disclosures are excluded from the count. 
• Abstracts must be structured using the following headings:

- Purpose

- Methods

- Results

- Conclusions

• Abstracts lacking results data (e.g., “results will be presented” and small sample size) will not be accepted.
• A maximum of one figure may be uploaded, but not required.
• Use standard scientific nomenclature and SI units where appropriate.
• Commercial/promotional language is not permitted.

• All listed authors must have made substantive scientific contributions to the work.
• The submitting author is responsible for ensuring the accuracy of all content, authorship information, and disclosures.
• Accepted abstracts may be assigned to oral or poster presentation formats at the discretion of the Scientific Program Committee.
• Submission of an abstract constitutes agreement that, if accepted, at least one author will register for and present the work at the meeting.
• Limit of two submissions per 1st author.

• Studies involving human participants must comply with the principles of the Declaration of Helsinki and applicable institutional review board or ethics committee requirements.
• Animal studies must comply with institutional and national guidelines for the care and use of laboratory animals.
• Clinical studies should indicate informed consent was obtained when applicable.

• Authors are responsible for the accuracy, originality, and scientific integrity of all submitted work. Generative artificial intelligence tools may not be listed as authors.
• Use of AI for editorial assistance, including grammar correction, spelling, formatting, or language refinement, does not require disclosure.
• Authors must disclose the use of generative AI if it contributed substantively to the scientific content of the submission, including generation or interpretation of data, drafting of scientific text, creation of figures or images, statistical analysis, or formulation of scientific conclusions.
• The Scientific Program Committee reserves the right to reject abstracts determined to contain inaccurate, fabricated, plagiarized, or insufficiently attributed AI-generated content.

• Submitting authors should disclose any financial interests related to the research presented. This may include compensation, financial support, patents, etc. Authors are advised to disclose if they are uncertain.

• Abstracts will undergo peer review by the Scientific Program Committee.
• Submitting authors acknowledge that accepted abstracts may be published in conference materials and associated meeting publications.
• Submission implies permission for publication of the abstract in meeting-related media.

Submissions are encouraged across the full spectrum of myopia research, including, and not limited to:

• Mechanisms of emmetropization and refractive development
• Animal models and translational research
• Clinical myopia management
• Optical, pharmacologic, and behavioral interventions
• Biomechanics and Structural Remodeling
• Imaging and ocular biometrics
• High myopia, pathology and structural changes
• Genetics and epidemiology
• Environmental and lifestyle risk factors
• Visual function and retinal physiology
• Public health and implementation science
• Artificial intelligence and myopia